These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34846443)

  • 1. Comparison of the uptake of untargeted and targeted immunostimulatory nanoparticles by immune cells in the microenvironment of metastatic breast cancer.
    Covarrubias G; Moon TJ; Loutrianakis G; Sims HM; Umapathy MP; Lorkowski ME; Bielecki PA; Wiese ML; Atukorale PU; Karathanasis E
    J Mater Chem B; 2022 Jan; 10(2):224-235. PubMed ID: 34846443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors.
    Bielecki PA; Lorkowski ME; Becicka WM; Atukorale PU; Moon TJ; Zhang Y; Wiese M; Covarrubias G; Ravichandran S; Karathanasis E
    Nanoscale Horiz; 2021 Feb; 6(2):156-167. PubMed ID: 33400743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer.
    Chen YP; Xu L; Tang TW; Chen CH; Zheng QH; Liu TP; Mou CY; Wu CH; Wu SH
    ACS Appl Mater Interfaces; 2020 Dec; 12(51):56741-56752. PubMed ID: 33305564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunostimulatory nanoparticle incorporating two immune agonists for the treatment of pancreatic tumors.
    Lorkowski ME; Atukorale PU; Bielecki PA; Tong KH; Covarrubias G; Zhang Y; Loutrianakis G; Moon TJ; Santulli AR; Becicka WM; Karathanasis E
    J Control Release; 2021 Feb; 330():1095-1105. PubMed ID: 33188827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
    Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
    Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity.
    Atukorale PU; Raghunathan SP; Raguveer V; Moon TJ; Zheng C; Bielecki PA; Wiese ML; Goldberg AL; Covarrubias G; Hoimes CJ; Karathanasis E
    Cancer Res; 2019 Oct; 79(20):5394-5406. PubMed ID: 31431457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can targeted nanoparticles distinguish cancer metastasis from inflammation?
    Choi AS; Moon TJ; Abuhashim W; Bhalotia A; Qian H; Paulsen KE; Lorkowski M; Ndamira C; Gopalakrishnan R; Krishnamurthy A; Schiemann WP; Karathanasis E
    J Control Release; 2023 Oct; 362():812-819. PubMed ID: 37011838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells.
    Song Y; Tang C; Yin C
    Biomaterials; 2018 Dec; 185():117-132. PubMed ID: 30241030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DTX@VTX NPs synergy PD-L1 immune checkpoint nanoinhibitor to reshape immunosuppressive tumor microenvironment for enhancing chemo-immunotherapy.
    Zhang R; Wan Y; Lv H; Li F; Lee CS
    J Mater Chem B; 2021 Sep; 9(36):7544-7556. PubMed ID: 34551052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor phagocytosis-driven STING activation invigorates antitumor immunity and reprograms the tumor micro-environment.
    Lee S; Hong KH; Park H; Ha J; Lee SE; Park DJ; Jeong SD; Kim S; Kim D; Ahn J; Lee HW; Koh WG; Ha SJ; Kim YC
    J Control Release; 2024 Sep; 373():55-69. PubMed ID: 38971428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-inflammatory chitosan/poly(γ-glutamic acid) nanoparticles modulate human antigen-presenting cells phenotype and revert their pro-invasive capacity.
    Castro F; Pinto ML; Silva AM; Pereira CL; Teixeira GQ; Gomez-Lazaro M; Santos SG; Barbosa MA; Gonçalves RM; Oliveira MJ
    Acta Biomater; 2017 Nov; 63():96-109. PubMed ID: 28919508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy.
    Li JX; Shu N; Zhang YJ; Tong QS; Wang L; Zhang JY; Du JZ
    ACS Appl Mater Interfaces; 2024 May; 16(20):25665-25675. PubMed ID: 38735053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment.
    Hsieh CH; Hsieh HC; Shih FS; Wang PW; Yang LX; Shieh DB; Wang YC
    Theranostics; 2021; 11(14):7072-7091. PubMed ID: 34093872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining Tumor Microenvironment Modulating Nanoparticles with Doxorubicin to Enhance Chemotherapeutic Efficacy and Boost Antitumor Immunity.
    Amini MA; Abbasi AZ; Cai P; Lip H; Gordijo CR; Li J; Chen B; Zhang L; Rauth AM; Wu XY
    J Natl Cancer Inst; 2019 Apr; 111(4):399-408. PubMed ID: 30239773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of 5'-triphosphate RNA with endosomolytic nanoparticles potently activates RIG-I to improve cancer immunotherapy.
    Jacobson ME; Wang-Bishop L; Becker KW; Wilson JT
    Biomater Sci; 2019 Jan; 7(2):547-559. PubMed ID: 30379158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of PEGylation on the efficacy and uptake of an immunostimulatory nanoparticle in the tumor immune microenvironment.
    Becicka WM; Bielecki PA; Lorkowski ME; Moon TJ; Zhang Y; Atukorale PU; Covarrubias G; Karathanasis E
    Nanoscale Adv; 2021 Aug; 3(17):4961-4972. PubMed ID: 34485818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer.
    Chandra D; Quispe-Tintaya W; Jahangir A; Asafu-Adjei D; Ramos I; Sintim HO; Zhou J; Hayakawa Y; Karaolis DK; Gravekamp C
    Cancer Immunol Res; 2014 Sep; 2(9):901-10. PubMed ID: 24913717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted therapeutic remodeling of the tumor microenvironment improves an HER-2 DNA vaccine and prevents recurrence in a murine breast cancer model.
    Liao D; Liu Z; Wrasidlo WJ; Luo Y; Nguyen G; Chen T; Xiang R; Reisfeld RA
    Cancer Res; 2011 Sep; 71(17):5688-96. PubMed ID: 21784871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.